🇺🇸 FDA
Company

Jazz

Jazz Pharmaceuticals plc

JAZZ pharma USA

Quick answer

Jazz is a pharma company (JAZZ) headquartered in DUBLIN, USA with 24 tracked pipeline programs.

Pipeline (24)

project

Atezolizumab

Small-Cell Lung Cancer

Phase 3 · small_molecule · active

1 trials project

Brincidofovir

Adenovirus Infection

Phase 3 · small_molecule · completed

1 trials project

Brincidofovir

Double-stranded DNA Virus

Phase 3 · small_molecule · completed

1 trials project

Brincidofovir

CMV

Phase 3 · small_molecule · completed

1 trials project

Brincidofovir

Cytomegalovirus Disease

Phase 3 · small_molecule · terminated

2 trials project

CPX-351

High Risk Acute Myeloid Leukemia

Phase 3 · small_molecule · completed

1 trials project

Cannabidiol (CBD)

Clinical High Risk for Psychosis (CHR)

Phase 3 · small_molecule · active

1 trials project

Cytarabine

Acute Myeloid Leukemia

Phase 3 · small_molecule · active

1 trials project

Defibrotide

Hepatic Veno-Occlusive Disease

Phase 3 · small_molecule · completed

2 trials project

Defibrotide

Severe Hepatic Veno-Occlusive Disease

Phase 3 · small_molecule · completed

1 trials project

Defibrotide

Veno-occlusive Disease

Phase 3 · small_molecule · completed

2 trials project

Dociparstat

Acute Myeloid Leukemia

Phase 3 · small_molecule · terminated

1 trials project

Dociparstat sodium

Coronavirus Disease 2019 (COVID-19)

Phase 3 · small_molecule · terminated

1 trials project

Dordaviprone (ONC201)

H3 K27M

Phase 3 · small_molecule · active

1 trials project

Everolimus

Diffuse Intrinsic Pontine Glioma

Phase 3 · small_molecule · active

1 trials project

GW-1000-02

Multiple Sclerosis

Phase 3 · small_molecule · completed

4 trials project

GW-1000-02

Pain

Phase 3 · small_molecule · completed

3 trials project

GWP42003-P

Rett Syndrome

Phase 3 · small_molecule · terminated

2 trials project

GWP42003-P

Seizure in Participants With Tuberous Sclerosis Complex

Phase 3 · small_molecule · terminated

1 trials project

GWP42003-P

Tuberous Sclerosis Complex

Phase 3 · small_molecule · completed

2 trials project

GWP42003-P

Epilepsy

Phase 3 · small_molecule · completed

5 trials project

GWP42003-P

Infantile Spasms

Phase 3 · small_molecule · completed

2 trials project

GWP42003-P

Seizures Associated With EMAS

Phase 3 · small_molecule · terminated

1 trials project

GWP42003-P 20 mg/kg/Day Dose

Epilepsy

Phase 3 · small_molecule · completed

3 trials

Drugs (8)

drug

asparaginase erwinia chrysanthemi (recombinant)-rywn

RYLAZE

 drug

calcium oxybate

XYWAV

 drug

cannabidiol

EPIDIOLEX

 drug

clozapine

CLOZAPINE

 drug

defibrotide sodium

DEFITELIO

 drug

fluvoxamine maleate

FLUVOXAMINE MALEATE

 drug

lurbinectedin

ZEPZELCA

 drug

zanidatamab-hrii

ZIIHERA

Patents (8)

patent

US 12427160

Use of cannabinoids in the treatment of epilepsy

Expires Mon Sep 25 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12403136

Cannabinoid derivatives as pharmaceutically active compounds and methods of prep

Expires Mon Aug 28 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12396963

Cannabidiol-type cannabinoid compound

Expires Mon Aug 21 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12383512

Cannabidiol-type cannabinoid compound

Expires Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12383567

Use of cannabinoids in the treatment of epilepsy

Expires Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12364670

Cannabidiol-type cannabinoid compound

Expires Mon Jul 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12357586

Use of the phytocannabinoid cannabidiol (CBD) in combination with a standard ant

Expires Mon Jul 10 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12350253

Use of cannabinoids in the treatment of dyskinesia associated with parkinson's d

Expires Mon Jul 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time)